Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @TheLancetOncol
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @TheLancetOncol
-
Prikvačeni tweet
Clinical picture quiz: What is the next best step in treatment? See thread for presentation and image.
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Perspectives: Quackery -
#Stemcell clinics: risk of proliferation https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30787-9/fulltext …@TSissung@WilliamFigg1Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Policy review: recommendations from the
#SISAQOL Consortium on international standards for the analysis of#qualityoflife and#patientreportedoutcome endpoints in#cancer#randomisedcontrolledtrialshttps://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30790-9/fulltext …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Online first: longterm results of the phase 3 New EPOC trial: systemic
#chemotherapy with or without#cetuximab in patients with resectable#colorectal#liver#metastasishttps://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30798-3/fulltext …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Very excited to launch a new
@TheLancetOncol Commission on childhood cancer@SiopAsia2020 — see you there?https://twitter.com/siopasia2020/status/1223931481417863169 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Review:
#MRI guided adaptive#radiotherapy for#liver#tumours: visualising the futurehttps://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30034-6/fulltext …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Clinical picture quiz: 74yo man with malignant pleural
#mesothelioma presents with worsening visual symptoms over 2weeks. MRI of the orbits reveals a new left orbital mass within the rectus muscle and encasing the optic nerve. What is the next best step in treatment?pic.twitter.com/2xdbSiJA4y
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Online first:
#Adjuvant#dabrafenib plus#trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III#melanoma: exploratory biomarker analyses from the phase 3 COMBI-AD trialhttps://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30062-0/fulltext …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Lancet Oncology proslijedio/la je Tweet
Two NEW modelling studies: Cervical cancer could be eliminated in countries worst affected by the disease, and 62 million women’s lives could be saved by 2120: 1) http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30068-4/fulltext … 2)http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30157-4/fulltext …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Perspectives: Spotlight -
#Chemotherapy for#resectable microsatellite instability-high#gastriccancer? YES: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30012-7 … NO: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30025-5 …@FlorianLordick@LizzySmyth1Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
New Editorial: New decade, new opportunities?https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30028-0/fulltext …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
See the inspiration for our Feb issue cover: Transcriptomic signatures related to the
#obesity paradox in patients with clear cell renal cell carcinoma: a cohort study Read the article here:https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30797-1/fulltext …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The February issue is now online. See https://www.thelancet.com/journals/lanonc/issue/current … for papers on
#renalcellcarcinoma,#lungcancer, Belantamab mafodotin for multiple#myeloma,#AI for#prostatecancer grading, and more!pic.twitter.com/yG8uqmi1Ln
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Lancet Oncology proslijedio/la je Tweet
PRESS RELEASE: Researchers develop first international standards for quality of life measurement in cancer https://www.eortc.org/blog/2020/01/31/press-release-researchers-develop-first-international-standards-for-quality-of-life-measurement-in-cancer/ …pic.twitter.com/X3oTC0ZWDY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Lancet Oncology proslijedio/la je Tweet
Top pick of 2019 #8 Gene signatures of quiescent
#glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment. Read the full#openaccess paper from Drs Friedel and Zou labs@LMU_Muenchen@SinaiBrain here -> https://bit.ly/37HSv8E pic.twitter.com/12jQvCa63j
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Lancet Oncology proslijedio/la je Tweet
Phosphorylated Rasal2 facilitates breast cancer progression. Get notified when
#openaccess papers like this are published. Register for content alerts from@TheLancet's@EBioMedicine→ https://hubs.ly/H0mzGxP0 pic.twitter.com/uV9lbXopJ9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Lancet Oncology proslijedio/la je Tweet
NEW viewpoint—Tumour lysis syndrome in patients with chronic lymphocytic leukaemia treated with BCL-2 inhibitors
#CLL#leusm Free to read w/ reg https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(19)30253-4/fulltext …pic.twitter.com/z6bskFjY7K
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Lancet Oncology proslijedio/la je Tweet
Our February issue is online now, featuring trials on transplantation, Waldenström macroglobulinemia, & AML, updates on GVHD & tumour-lysis syndrome, art & pain in
#hematology,#SickleCell disease in Africa & more!#bmtsm#leusm#wmsm https://www.thelancet.com/journals/lanhae/issue/current …pic.twitter.com/dOPhmAPWqE
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Lancet Oncology proslijedio/la je Tweet
As part of the
#Lancet2020 campaign on child & adolescent health & ahead of#InternationalChildhoodCancerDay, our Editorial discusses the first global analysis of funding for childhood cancer research & calls for its consideration as a political priority https://hubs.ly/H0mNF8p0 pic.twitter.com/HyFr6dolMZ
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.